Lv4
700 积分 2025-04-09 加入
Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling
3天前
已完结
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
1个月前
已完结
Minocycline Therapy for Traumatic Wound Infections Caused by the Multidrug-Resistant Acinetobacter baumannii-Acinetobacter calcoaceticus Complex
2个月前
已关闭
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Selection of Antibiotic Therapy for Complicated UTI
2个月前
已关闭
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods
2个月前
已关闭
How to Treat Carbapenem-Resistant Acinetobacter baumannii Infections
2个月前
已关闭
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
2个月前
已完结
Emerging threat of WHO priority pathogens in ICU-associated CLABSI and CAUTI: an integrated analysis of resistance patterns, epidemiological trends, and stewardship strategies
2个月前
已完结
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
2个月前
已完结
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2个月前
已完结
皖公网安备34019202002308
